全球動物模型市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

動物模型市場預計將從 2025 年的 32.4 億美元成長到 2034 年的 70.8 億美元，2026 年至 2034 年的複合年成長率為 9.07%。

受藥物研發、疾病研究和生物技術領域研究不斷深入的推動，全球動物模型市場呈現穩定成長態勢。動物模型在臨床前試驗和理解複雜生物學過程方面發揮著至關重要的作用。製藥業研發投入的增加以及慢性病的盛行率上升，都顯著促進了市場擴張。

成長要素包括基因工程的進步、對個人化醫療日益成長的需求以及生物醫學研究舉措的擴展。基因改造和人源化動物模型的開發提高了研究的準確性和效率。政府和學術界對生命科學研究的資助也進一步促進了市場成長。

預計未來市場將持續成長，主要得益於生物技術和精準醫療領域的創新。倫理考量和法規結構將繼續影響研究實踐。諸如晶片器官技術等新興替代方案或許能在不久的將來與動物模型形成互補，但不太可能完全取代動物模型。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球動物模型市場：依應用範圍分類

• 市場分析、洞察與預測
• 癌症
• 免疫疾病
• 感染疾病
• 其他

第5章：全球動物模型市場：依動物種類和範圍分類

• 市場分析、洞察與預測
• 老鼠
• 鼠
• 天竺鼠
• 兔子
• 倉鼠
• 其他

第6章：全球動物模型市場：依最終用途分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術研究機構
• 合約研究機構

第7章：全球動物模型市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Charles River Laboratories
  • The Jackson Laboratory
  • GenOway
  • Taconic Biosciences Inc
  • Janvier Labs
  • Harbour BioMed
  • Crown Bioscience
  • Inotiv
  • Biocytogen
  • BioSpherix Ltd
  • Animal M

The Animal Model Market size is expected to reach USD 7.08 Billion in 2034 from USD 3.24 Billion (2025) growing at a CAGR of 9.07% during 2026-2034.

The Global Animal Model Market has witnessed steady growth due to increasing research in drug development, disease studies, and biotechnology. Animal models play a critical role in preclinical testing and understanding complex biological processes. Rising investments in pharmaceutical R&D and the growing prevalence of chronic diseases have significantly supported market expansion.

Growth drivers include advancements in genetic engineering, increasing demand for personalized medicine, and expanding biomedical research initiatives. The development of transgenic and humanized animal models has enhanced research accuracy and efficiency. Government and academic funding for life sciences research further strengthens market growth.

In the future, the market is expected to grow alongside innovation in biotechnology and precision medicine. Ethical considerations and regulatory frameworks will continue shaping research practices. Emerging alternatives such as organ-on-chip technologies may complement, but not fully replace, animal models in the near term.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application Scope

• Cancer
• Immunological Disease
• Infectious Disease
• Others

By Animal Type Scope

• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

By End-use

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization

COMPANIES PROFILED

• Charles River Laboratories, The Jackson Laboratory, genOway, Taconic Biosciences Inc, Janvier Labs, Harbour BioMed, Crown Bioscience, Inotiv, Biocytogen, BioSpherix Ltd, Animal M

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL MODEL MARKET: BY APPLICATION SCOPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application Scope
• 4.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunological Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Infectious Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANIMAL MODEL MARKET: BY ANIMAL TYPE SCOPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type Scope
• 5.2. Mice Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Guinea Pigs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Rabbits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Hamsters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANIMAL MODEL MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic Research Institute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANIMAL MODEL MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application Scope
  • 7.2.2 By Animal Type Scope
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application Scope
  • 7.3.2 By Animal Type Scope
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application Scope
  • 7.4.2 By Animal Type Scope
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application Scope
  • 7.5.2 By Animal Type Scope
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application Scope
  • 7.6.2 By Animal Type Scope
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ANIMAL MODEL INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Charles River Laboratories
  • 9.2.2 The Jackson Laboratory
  • 9.2.3 GenOway
  • 9.2.4 Taconic Biosciences Inc
  • 9.2.5 Janvier Labs
  • 9.2.6 Harbour BioMed
  • 9.2.7 Crown Bioscience
  • 9.2.8 Inotiv
  • 9.2.9 Biocytogen
  • 9.2.10 BioSpherix Ltd
  • 9.2.11 Animal M